1. Home
  2. JAGX vs LMFA Comparison

JAGX vs LMFA Comparison

Compare JAGX & LMFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • LMFA
  • Stock Information
  • Founded
  • JAGX 2013
  • LMFA 2008
  • Country
  • JAGX United States
  • LMFA United States
  • Employees
  • JAGX N/A
  • LMFA N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • LMFA Finance: Consumer Services
  • Sector
  • JAGX Health Care
  • LMFA Finance
  • Exchange
  • JAGX Nasdaq
  • LMFA Nasdaq
  • Market Cap
  • JAGX 11.3M
  • LMFA 9.2M
  • IPO Year
  • JAGX N/A
  • LMFA 2015
  • Fundamental
  • Price
  • JAGX $0.86
  • LMFA $2.28
  • Analyst Decision
  • JAGX
  • LMFA Hold
  • Analyst Count
  • JAGX 0
  • LMFA 1
  • Target Price
  • JAGX N/A
  • LMFA N/A
  • AVG Volume (30 Days)
  • JAGX 505.4K
  • LMFA 149.6K
  • Earning Date
  • JAGX 11-13-2024
  • LMFA 11-13-2024
  • Dividend Yield
  • JAGX N/A
  • LMFA N/A
  • EPS Growth
  • JAGX N/A
  • LMFA N/A
  • EPS
  • JAGX N/A
  • LMFA N/A
  • Revenue
  • JAGX $10,480,000.00
  • LMFA $12,838,084.00
  • Revenue This Year
  • JAGX $32.33
  • LMFA N/A
  • Revenue Next Year
  • JAGX $43.63
  • LMFA N/A
  • P/E Ratio
  • JAGX N/A
  • LMFA N/A
  • Revenue Growth
  • JAGX N/A
  • LMFA 27.81
  • 52 Week Low
  • JAGX $0.84
  • LMFA $2.18
  • 52 Week High
  • JAGX $21.60
  • LMFA $6.11
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 40.81
  • LMFA 34.52
  • Support Level
  • JAGX $0.84
  • LMFA $2.67
  • Resistance Level
  • JAGX $1.29
  • LMFA $2.90
  • Average True Range (ATR)
  • JAGX 0.09
  • LMFA 0.25
  • MACD
  • JAGX -0.01
  • LMFA -0.06
  • Stochastic Oscillator
  • JAGX 3.59
  • LMFA 8.49

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About LMFA LM Funding America Inc.

LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.

Share on Social Networks: